Company Details
icon-plc-2
36,427
577,622
541714
iconplc.com
0
ICO_2948584
In-progress
ICON plc Company CyberSecurity Posture
iconplc.comSince our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
Company Details
icon-plc-2
36,427
577,622
541714
iconplc.com
0
ICO_2948584
In-progress
Between 750 and 799
ICON plc Global Score (TPRM)XXXX


No incidents recorded for ICON plc in 2025.
No incidents recorded for ICON plc in 2025.
No incidents recorded for ICON plc in 2025.
ICON plc cyber incidents detection timeline including parent company and subsidiaries

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.


At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac
.png)
ICON plc released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of 2023...
DUBLIN, December 02, 2025--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest...
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
DUBLIN, November 12, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that...
Exploring Ronald Muhlenkamp (Trades, Portfolio)'s Latest 13F Filing and Investment Strategies.
Betsy Cooper, a Yale-trained lawyer with Oxford degrees, entered cybersecurity by chance. She's now a crucial advocate for businesses and...
Icon PLC (ICLR) reports steady revenue growth and robust cash flow, while addressing margin pressures and competitive challenges in the...
Icon PLC (ICLR) delivered earnings and revenue surprises of +0.91% and +3.03%, respectively, for the quarter ended September 2025.
Highlights. Quarter three revenue was $2,042.8 million representing an increase of 1.3% on quarter two 2025. Net income for the quarter was...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of ICON plc is http://www.iconplc.com.
According to Rankiteo, ICON plc’s AI-generated cybersecurity score is 795, reflecting their Fair security posture.
According to Rankiteo, ICON plc currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, ICON plc is not certified under SOC 2 Type 1.
According to Rankiteo, ICON plc does not hold a SOC 2 Type 2 certification.
According to Rankiteo, ICON plc is not listed as GDPR compliant.
According to Rankiteo, ICON plc does not currently maintain PCI DSS compliance.
According to Rankiteo, ICON plc is not compliant with HIPAA regulations.
According to Rankiteo,ICON plc is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
ICON plc operates primarily in the Biotechnology Research industry.
ICON plc employs approximately 36,427 people worldwide.
ICON plc presently has no subsidiaries across any sectors.
ICON plc’s official LinkedIn profile has approximately 577,622 followers.
ICON plc is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
Yes, ICON plc has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/icon-plc.
Yes, ICON plc maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/icon-plc-2.
As of December 14, 2025, Rankiteo reports that ICON plc has not experienced any cybersecurity incidents.
ICON plc has an estimated 4,489 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, ICON plc has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
A weakness has been identified in itsourcecode Online Pet Shop Management System 1.0. This vulnerability affects unknown code of the file /pet1/addcnp.php. This manipulation of the argument cnpname causes sql injection. The attack can be initiated remotely. The exploit has been made available to the public and could be exploited.
A security flaw has been discovered in Tenda AX9 22.03.01.46. This affects the function image_check of the component httpd. The manipulation results in use of weak hash. It is possible to launch the attack remotely. A high complexity level is associated with this attack. It is indicated that the exploitability is difficult. The exploit has been released to the public and may be exploited.
A weakness has been identified in code-projects Student File Management System 1.0. This issue affects some unknown processing of the file /admin/update_student.php. This manipulation of the argument stud_id causes sql injection. The attack is possible to be carried out remotely. The exploit has been made available to the public and could be exploited.
A security flaw has been discovered in code-projects Student File Management System 1.0. This vulnerability affects unknown code of the file /admin/save_user.php. The manipulation of the argument firstname results in sql injection. The attack can be executed remotely. The exploit has been released to the public and may be exploited.
A vulnerability was identified in code-projects Student File Management System 1.0. This affects an unknown part of the file /admin/update_user.php. The manipulation of the argument user_id leads to sql injection. Remote exploitation of the attack is possible. The exploit is publicly available and might be used.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.